September 28, 2011

Without proper treatment, half of the 370,000 children newly infected with HIV last year will die before they reach their second birthday. But very few medicines are designed and adapted specifically for children, and are affordable and practical to use in the places where they live. The Drugs for Neglected Diseases initiative (DNDi) recently announced a new project to help develop appropriate HIV drugs for children.

June 08, 2011

New research has proved conclusively that treatment of HIV can reduce the transmission of the disease from one person to another by 96 percent. In other words, HIV treatment is also HIV prevention. The UN Summit on HIV/AIDS starts on June 8 and officials will decide on a blueprint for the next decade of the global response to the epidemic. Will global leaders act now to save millions of lives and prevent millions of new infections?

December 01, 2010

Treating children with HIV goes beyond putting them on medication. Patient support specifically targeted to children helps motivate them to stick with their treatment regimen. But there has yet to be a scientific study to help determine the best practices for providing this support.

November 23, 2010

In Kenya, more than 22,000 children were infected with HIV in 2009. The district of Homa Bay,  in rural western Kenya, has the country’s highest HIV prevalence rate. MSF is working to stop the spread of the disease in Homa Bay with its prevention of mother-to-child transmission (PMTCT) program.

November 07, 2010

Generic versions of antiretrovirals, or ARVs, that cost a fraction of the price of brand medicines make it possible for MSF to treat 160,000 people living with HIV around the world. Eighty percent of the ARVs we use come from India, and millions of others in developing countries depend on India-made generics as well. But the European Commission has begun directing its trade policies in a way that could stamp out the production of lifesaving generics in India. MSF has launched a global public campaign to tell Europe to back off, and to honor its commitments to global health.

September 27, 2010

Patients in developing countries who will soon need new treatment regimens for HIV/AIDS will be even more unlikely to receive them, now that international donors are walking away from their funding promises.

September 20, 2010

Better drugs, administered sooner to HIV/AIDS patients is better for all parties involved; but donors are focused on short-term costs.

September 13, 2010

People living with HIV/AIDS are already feeling the impact as international funders back away from promises to fund treatment in developing countries.

August 24, 2010

Less than 100 babies contract HIV from their mothers in US every year, while 18,000 known cases occur in Uganda. We visit one MSF-supported program to prevent such transmission, in Madi Opei.

June 24, 2010

The HIV-TB dual epidemic in Swaziland: one in four adults in the country has HIV, the highest prevalence in the world; and with compromised immune systems, people living with HIV are much more susceptible to other deadly diseases, including TB and its drug-resistant forms. MSF is using innovative ways to treat this deadly dual epidemic in a challenging environment.